Scientists demonstrated that the expression and activation of the mitochondrial fission mediator dynamin-related protein 1 (DRP1) were affected by chemotherapy exposure in common pediatric sarcomas, namely, rhabdomyosarcoma and osteosarcoma.
[Life Science Alliance]
